Prof. Hedan Bai is an Assistant Professor at the Department of Materials, ETH Zürich, specializing in robotics materials, bio-inspired systems, and soft robotics. Their research focuses on developing advanced materials for sensing, energy-efficient systems, and biomedical applications. Notable projects include the SmartSuit architecture for space exploration and self-healing optical sensors for soft robots. Research interests span bioelectronics, stretchable sensors, haptic interfaces, and biomimetic materials. Bai's work integrates material science with robotics to create adaptive, sustainable, and intelligent systems. Key areas include wireless implants for neuromodulation, environmental-responsive textiles, and energy-harvesting devices. Publications highlight innovations in optical waveguides, self-healing materials, and wearable technologies. Their interdisciplinary approach bridges robotics, biomedical engineering, and aerospace applications. No formal awards are listed, but contributions to next-gen materials for robotics are prominent. Advising and grants are not detailed in the text, but Bai's lab focuses on projects like SmartSuit for extravehicular activities and synthetic afferent neural networks. Collaborations likely involve aerospace and biomedical sectors.
Dr. Camila Aquino serves as Assistant Professor in both the Department of Clinical Neurosciences and Department of Community Health Sciences at the University of Calgary's Cumming School of Medicine, and is a Full Member of the Hotchkiss Brain Institute. As Medical Director of the Deep Brain Stimulation Program, she specializes in Parkinson's disease, essential tremor, dystonia, and chorea management, including EMG-guided botulinum toxin injections. Her educational background includes: M.D. in Medicine from Escola Superior de Ciencias da Santa Casa (2005) M.S. in Neurosciences from Federal University of Sao Paulo (2012) Ph.D. in Neurosciences from Federal University of Sao Paulo (2019) M.S. in Health Research Methods, Clinical Epidemiology from McMaster University (2020) Dr. Aquino's research addresses unmet needs in movement disorders through innovative clinical trial designs for Parkinson's disease, focusing on precision-medicine approaches, early intervention, and outcome optimization. She actively evaluates neuromodulation therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and MRgFUS, with emphasis on expanding indications and improving patient outcomes. As an International Parkinson and Movement Disorder Society member, she chairs the web-based learning committee and serves on evidence-based medicine and outcome measure committees. Analysis of her 15 most recent publications (2021-2025) reveals a cohesive research trajectory centered on Parkinson's disease management, with dominant themes in motor fluctuation treatments, deep brain stimulation methodology, and clinical trial innovation. Her work bridges fundamental clinical practice guidelines with advanced neuromodulation technologies, demonstrating consistent commitment to evidence-based solutions for movement disorders. Her scientific recognition includes: Parkinson Canada research grant Mohammed Al Zaibak Foundation scholarship CAPES scholarship from Brazilian Ministry of Education Dr. Aquino has secured significant research funding supporting clinical trials in Parkinson's disease neuroprotection and neuromodulation therapies. While specific student advisees aren't listed, her leadership of the DBS Program and active clinical trial portfolio indicate substantial mentorship responsibilities. Her grant portfolio emphasizes translational research with direct clinical impact. She directs the University of Calgary's Deep Brain Stimulation Program and contributes to the MRI-guided focused ultrasound initiative. Through her International Parkinson and Movement Disorder Society committee roles, she shapes global educational standards and evidence-based practices in movement disorders.
Dr. Keith Alexander Sharkey is a Professor in the Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. He is also a Full Member of both the Hotchkiss Brain Institute and The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases. Dr. Sharkey has been at the University of Calgary since his appointment as Assistant Professor in 1990, dedicating his career to understanding the neural control of the gastrointestinal tract. From 2005-2021, he held the Crohn's and Colitis Canada Chair in Inflammatory Bowel Disease Research, demonstrating his longstanding commitment to advancing knowledge in gastrointestinal sciences. Dr. Sharkey's educational journey began with a BSc (Hons) in Nutrition from the University of London in 1981, followed by a PhD in Physiology from the University of Liverpool in 1985. After completing postdoctoral training in Hungary, the UK, and Canada, he joined the University of Calgary faculty in 1990, where he has remained throughout his distinguished academic career. Dr. Sharkey's research program centers on understanding the physiology and pathophysiology of the neural control of the gastrointestinal tract and brain-gut interactions in health and disease. His laboratory investigates two main areas: the role of the endocannabinoid system in regulating GI motility and intestinal barrier function, and the physiology of the enteric nervous system in controlling motility and barrier function. His work employs state-of-the-art approaches including live cell imaging and molecular genetics. Recent publications show his expanding interest in connections between gut function and neurodegenerative conditions like ALS, with multiple 2024-2025 papers examining sexual dimorphism in disease processes and gut-brain axis mechanisms. Fellow, Royal Society of Canada (2024) Cumming School of Medicine's van de Sande Distinguished Achievement Award for Mentorship (2021) Distinguished Research Award, American Physiological Society (2021) Finkelstein Award for Excellence, Crohn's and Colitis Canada (2016) Fellow, Canadian Academy of Health Sciences (2015) Fellow, Canadian Association of Gastroenterology (2015) Killam Annual Professor Award, University of Calgary (2013) Dr. Sharkey has mentored numerous students throughout his career, as evidenced by his 2021 Mentorship Award. His research is supported by significant funding, including a CIHR Foundation grant exploring how enteric nerves and glia maintain intestinal homeostasis. He has also participated in university strategic initiatives focused on Brain and Mental Health (2015-2021) and Infections, Inflammations and Chronic Diseases (2015-2021), demonstrating his interdisciplinary approach. The Sharkey Lab provides a safe, inclusive, and diverse research environment that encourages open scientific exchange from diverse viewpoints. His laboratory is actively engaged in multiple collaborative projects, including investigations with UBC Okanagan on diet and probiotics targeting the gut-brain metabolic interactome, and with University of Calgary colleagues studying gut microbiota's role in ALS. Dr. Sharkey continues to advance our understanding of neural mechanisms controlling gastrointestinal function with upcoming courses scheduled for Fall 2024 and Winter 2025.
Dr. Yamin Zhang (张亚敏) holds a Presidential Young Professorship as an Assistant Professor in the Department of Chemical & Biomolecular Engineering at the National University of Singapore (NUS), College of Engineering. She leads the Zhang Group which focuses on interdisciplinary research at the intersection of electrochemistry, materials science, and biomedical engineering. 07/2023 – 01/2024: Research Associate, Northwestern University 02/2021 – 06/2023: Postdoctoral Fellow, Northwestern University 08/2016 – 12/2020: Ph.D., Chemical Engineering, Georgia Institute of Technology 09/2012 – 07/2016: B.S., Chemical Engineering, Tianjin University; B.S., Finance (Double Major), Nankai University Dr. Zhang's research centers on developing advanced electrochemical strategies for next-generation medical devices (implantable, bioresorbable, and wearable) and sustainable energy solutions. Her work bridges bioelectronics , battery technology , and medical therapeutics , with particular emphasis on creating devices that can safely dissolve in the body after serving their purpose. Key areas include bioresorbable optoelectronic systems for electrotherapy, self-powered drug delivery platforms, and eco-safe battery technologies that can harmlessly resorb in biological environments. Analysis of Dr. Zhang's publication record reveals a clear trajectory from fundamental battery chemistry (2021-2022) toward increasingly sophisticated medical applications (2023-2025). Her recent work demonstrates mastery in integrating multiple functionalities into single bioresorbable platforms, as evidenced by her Nature (2025) paper on millimeter-scale optoelectronic systems for electrotherapy and Cell Biomaterials (2025) paper on wireless bioelectronic devices. The research shows strong interdisciplinary collaboration with leading institutions including Northwestern University and Georgia Tech. AHA Early Faculty Independence Award (2023) MIT ChemE Rising Stars (2022) Sigma Xi Best PhD Thesis Award (2021) Chinese Government Award for Outstanding Students Abroad (2021) A*STAR MTC Young Individual Research Grants (YIRG) (2025) Early Career Board Member for ACS Applied Materials & Interfaces (2025) Dr. Zhang has secured significant research funding including the AHA's Second Century Early Faculty Independence Award as Principal Investigator (2023) and the A*STAR MTC Young Individual Research Grant (2025). Her group serves on advisory boards for Cell Biomaterials and ACS Applied Materials & Interfaces. The Zhang Group at NUS maintains active collaborations with Northwestern University researchers including the Rogers group, with whom she has co-authored multiple high-impact publications in Nature, Science, and PNAS. Current research focuses on advancing battery technology and developing sophisticated electrochemical strategies for medical devices with an overarching focus on healthcare innovation and environmental sustainability.
Swiss Federal Institute of Technology in LausanneSwitzerland
Silvestro Micera is a Full Professor at the Swiss Federal Institute of Technology Lausanne (EPFL) and holds the Bertarelli Foundation Chair in Translational Neuroengineering. He directs the Translational Neural Engineering Laboratory and teaches courses including Neural signals and signal processing and Translational neuroengineering . His research bridges neural interfaces, robotics, and neuroprosthetics to restore motor functions in spinal cord injuries, stroke, and amputations. Micera's research integrates implantable neural interfaces, robotic rehabilitation, and hybrid neuro-prosthetic systems. Key focus areas include: Robotic neurorehabilitation for mobility restoration Neural control mechanisms in movement CNS/PNS neural interface development Bioelectronic modulation for sensory feedback His recent publications emphasize machine learning-driven motor recovery prediction, closed-loop sensory feedback systems, and minimally invasive neuroprosthetics. Trends include AI-optimized stimulation protocols, multimodal data fusion for rehabilitation, and clinical translation of neural bypass technologies. Awards: IEEE EMBS Early Career Achievement Award (2009) IEEE EMBS Technical Achievement Award (2021) Micera leads EU-funded projects such as TIME, CLONS, and NeuWalk, focusing on neural prostheses. He advises 8 current and 18 former PhD students in neuroengineering. His lab collaborates with MIT, Harvard, and industry partners (e.g., Plexon) to advance translational neurotechnologies.
Michel M. Maharbiz is a Professor in the Department of Electrical Engineering and Computer Science at the University of California, Berkeley. He leads research on miniaturized bioelectronic interfaces, including neural dust implants and cyborg insects. He holds affiliations with the Berkeley Sensor & Actuator Center (BSAC), Center for Neural Engineering & Prostheses (CNEP), and SWARM Lab. His education includes a Ph.D. in EECS from UC Berkeley (2003) and a B.S. in EE from Cornell University (1997). Maharbiz's research integrates MEMS, ultrasonic systems, and synthetic biology to develop wireless neural interfaces, implantable sensors, and biohybrid devices. Key focus areas are neural dust technology for peripheral nerve recording, magnetoelastic strain sensors for medical applications, and electrochemical biosensing using bacterial flagellar motors. His publications emphasize neural interfaces, ultrasonic implants, and biomedical monitoring. Recent articles explore ultrasonic power delivery (2025), radiation detectors for oncology (2025), and fracture-healing smart plates (2019). Trends include miniaturization of wireless implants, closed-loop therapeutic systems, and novel biomaterials. Scientific Awards: McKnight Technological Innovations in Neuroscience Award (2017) Chan-Zuckerberg Biohub Investigator (2017) NSF CAREER Award (2009) MIT TR10 Top Emerging Technology (2009) Bakar Fellows Spark Award (2012) He directs the Maharbiz Lab, advancing neural dust and bioelectronic interfaces. Projects include impedance-based fracture monitoring, carbon fiber neural arrays, and hernia repair sensors. Funding includes NSF and industry partnerships for implantable device development.
Jeffrey Schall is a Full Professor of Biology and Program Director of the Visual Neurophysiology Centre at York University. He holds the Canada Research Chair in Translating Neuroscience. His research focuses on neural mechanisms underlying behavior, integrating neurophysiological and computational approaches across multiple scales. Schall is a core member of the Centre for Vision Research and the Canada First Research Excellence Fund Connected Minds initiative. Education: PhD in Anatomy (University of Utah School of Medicine, 1986), postdoctoral training at MIT. Awards include the Troland Research Award, Sloan Foundation Fellowship, and AAAS Fellowship. He served as Vision Science Society President in 2019. Research interests include visual attention, executive control, error monitoring, and translational neuroscience applications in law. His work bridges basic science with applied studies in clinical populations like schizophrenia patients. Collaborative projects involve EEG/MEG analysis, cortical microcircuitry modeling, and neuromodulation techniques. Teaching: YU_NRSC 2100 Systems, Behavioral, and Cognitive Neuroscience. Active in interdisciplinary initiatives linking neuroscience with legal systems through scholarship and policy engagement.
Dr. Birgit Frauscher is the Lincoln Financial Group Distinguished Professor in Neurobiology at Duke University School of Medicine, where she serves as Professor of Neurology and holds a secondary appointment in the Department of Biomedical Engineering at the Duke Pratt School of Engineering. She is currently the Director of the Duke Comprehensive Epilepsy Center and leads the Analytical Neurophysiology (ANPHY) Lab. Her clinical and research work focuses on epilepsy and sleep medicine, utilizing both invasive and non-invasive electrical recordings to study brain activity in humans. Dr. Frauscher completed her medical training, neurology residency, and subspecialty training in electroencephalography, epilepsy, and sleep medicine at the Medical University of Innsbruck in Austria. After completing her clinical training in 2008, she earned her habilitation degree in 2011. She further specialized in intracranial EEG and signal analysis during a visiting professorship at the Montreal Neurological Institute and Hospital, McGill University (2013-2015), where she later served as an Attending Epileptologist and Group Leader of Epilepsy. Her research interests focus on developing novel seizure-independent EEG markers for the epileptogenic zone, investigating sleep-epilepsy interactions, and using intracranial EEG to study brain physiology during wakefulness and sleep. Her work aims to improve epilepsy diagnosis, prognosis, and treatment outcomes by better localizing the epileptic focus. Dr. Frauscher's recent publications demonstrate her continued leadership in epilepsy research, with over 170 peer-reviewed papers and an H-index of 62. Dr. Frauscher has received several prestigious awards including the Clinician-Scientist awards of the FRSQ (2018-2023), the Michael Prize of the International League against Epilepsy (2019), and the Ernst Niedermeyer Prize from the Austrian Epilepsy Society (2015). Her scholarly work has significantly advanced clinical knowledge in epilepsy and sleep medicine, establishing her as a leading figure in the field. As Director of the Duke Comprehensive Epilepsy Center and head of the ANPHY lab, Dr. Frauscher oversees a research program dedicated to advancing neuroscience through innovative approaches to studying brain activity. Her lab employs quantifiable tools to investigate neurophysiological and pathological processes related to epilepsy and sleep, with the ultimate goal of improving patient outcomes through better understanding of brain function.
Marc V Fuccillo is an Associate Professor of Neuroscience at the Perelman School of Medicine, University of Pennsylvania, where he leads a research laboratory focused on understanding the neural circuit mechanisms underlying behavioral control. His work bridges molecular, synaptic, and behavioral approaches to investigate how striatal circuits regulate mouse behavior from simple motor patterns to complex goal-directed actions. Fuccillo holds dual appointments in the Neuroscience and Cell and Molecular Biology Graduate Groups at Penn and maintains an active laboratory investigating the synaptic and circuit basis of neuropsychiatric disorders. Education: B.A. in Molecular and Cellular Biology and Music Performance (Violin) from Brown University (1998) Ph.D. in Developmental Genetics from New York University School of Medicine (2007) M.D. from New York University School of Medicine (2008) Fuccillo's research centers on the synaptic and circuit mechanisms of behavioral control, with particular emphasis on striatal circuits. His laboratory employs a range of technologies including mouse genetics, in vitro electrophysiology, in vivo imaging, and quantitative behavioral analysis to explore how neural circuits of the striatum regulate behavior and how disruptions in these circuits contribute to neuropsychiatric disorders. His work has particularly focused on autism-associated abnormalities in behavioral control, examining how synaptic adhesion molecules like neuroligins and neurexins shape circuit function and behavior, with significant findings regarding D1 dopamine receptor positive medium spiny neurons in the nucleus accumbens. Analysis of Fuccillo's recent publications reveals a strong focus on striatal circuit function across multiple dimensions. His work spans molecular neuroscience (examining synaptic adhesion molecules), cellular physiology (studying specific neuron types in striatal circuits), systems neuroscience (mapping circuit connectivity), and behavioral neuroscience (quantifying motor learning and decision-making). A unifying theme is how disruptions in specific molecular pathways lead to circuit-level abnormalities that manifest as behavioral phenotypes relevant to neuropsychiatric disorders, with particular attention to autism, OCD, and schizophrenia models. Scientific Recognition: Publications in high-impact journals including Nature Neuroscience, Current Biology, Cell Reports, and Neuron Research supported by multiple NIH grants including NIMH F32, NIMH K01, and HHMI Gilliam Fellowship awards for lab members Fuccillo actively mentors a diverse group of trainees including postdoctoral fellows, graduate students, and undergraduates. His laboratory has produced numerous successful alumni who have gone on to faculty positions, medical residencies, and graduate programs at prestigious institutions. His mentoring approach emphasizes technical skill development across multiple neuroscience disciplines while fostering independent scientific thinking. Current research in his lab is supported by NIH funding focused on understanding the molecular architecture of striatal circuits and their role in behavioral control, with three major research directions exploring molecular logic of striatal circuits, circuit mechanisms of behavioral control, and striatal dysfunction in neuropsychiatric disease models. The Fuccillo Laboratory operates within the Department of Neuroscience at the University of Pennsylvania, with access to state-of-the-art facilities for molecular, electrophysiological, imaging, and behavioral neuroscience research. The lab maintains active collaborations with other neuroscience research groups at Penn and beyond, creating a rich intellectual environment for studying the neural basis of behavior. Current research directions include investigating whether there is a molecular logic to striatal circuit composition, how striatal circuits shape behavioral control, and what mouse models of autism, schizophrenia, and OCD can reveal about striatal circuit dysfunction in disease pathophysiology.
University of California, Los AngelesUnited States
Aydin Babakhani is a Professor in the Department of Electrical and Computer Engineering at the University of California, Los Angeles (UCLA), affiliated with the College of Life Sciences. He directs the Integrated Sensors Laboratory (ISL), which focuses on the design and implementation of integrated sensors and systems. His research spans high-speed wireless communication, terahertz technology, medical implants, radar systems, and industrial monitoring solutions. Research Interests: Prof. Babakhani's work integrates silicon-based technologies with applications across multiple domains. Key areas include: Silicon mm-Wave/THz transceivers and on-chip antennas for communication and sensing Wirelessly powered medical implants for biopotential monitoring and neural stimulation THz radar systems for micrometer-resolution imaging and vibration detection Energy harvesting solutions for batteryless sensors in industrial and biomedical applications CMOS-based optoelectronic systems and photonic computing accelerators His recent publications (2021-2025) demonstrate a strong emphasis on terahertz systems, wireless power transfer, and miniaturized medical electronics. Over 80% of his latest articles involve silicon-integrated solutions for biomedical implants or THz sensing, with emerging focus on AI-accelerated photonic computing and multi-Gbps wireless links.
University of California, San FranciscoUnited States
Lindsey Draper, MD serves as an Adjunct Instructor in the Roybal Laboratory within the Department of Medicine, Division of Hematology and Oncology at the University of California San Francisco School of Medicine. Her clinical practice focuses on the treatment of patients with recurrent ovarian cancer using systemic therapies including chemotherapy and immunotherapy, with a commitment to evaluating and offering clinical trial opportunities as part of individualized patient care. Dr. Draper completed her educational training with a B.S. in Biology from Juniata College (2010), an M.D. from the University of Maryland School of Medicine (2017), an Internal Medicine Residency at The Mount Sinai Hospital (2022), and is currently completing a Medical Oncology Fellowship at UCSF (2025-2027). Her research interests center on cancer immunotherapy, particularly T cell-based approaches for HPV-associated cancers and ovarian cancer. She investigates engineered T cell therapies targeting viral antigens in cervical and other HPV-related cancers, with a focus on overcoming treatment resistance and improving clinical outcomes through novel immunotherapeutic strategies. Her work bridges fundamental immunological mechanisms with clinical applications, emphasizing the translation of laboratory discoveries into patient treatments. Dr. Draper's publication record demonstrates consistent contributions to the field of cancer immunotherapy, with recent work focusing on TCR-engineered T cells for leukemia and HPV-associated malignancies. Her research trajectory shows increasing sophistication in T cell engineering approaches and a growing emphasis on addressing inflammatory responses and treatment resistance mechanisms. Parker Institute for Cancer Immunotherapy Early Career Research Award: Parker Scholar (2024) Gladstone-UCSF Institute of Genomic Immunology Symbiont Seed Grant for 'Antigen Discovery for Ovarian Cancer' (2024) Conquer Cancer Young Investigator Award, American Society of Clinical Oncology (2024) Women in Cancer Immunotherapy Network Leadership Institute Selected Participant, Society for Immunotherapy of Cancer (2024) Physician-Scientist Fellow, Chan Zuckerberg Biohub - San Francisco (2023-2025) As a physician-scientist, Dr. Draper maintains an active research program while providing clinical care, with particular emphasis on developing novel immunotherapies for gynecologic cancers. Her current fellowship at UCSF and multiple early-career awards indicate strong potential for continued contributions to the field of cancer immunotherapy. Dr. Draper works within the Roybal Laboratory at UCSF, which focuses on innovative approaches to cancer immunotherapy and T cell engineering. Her research intersects with multiple collaborative initiatives at UCSF, including the Parker Institute for Cancer Immunotherapy and the Gladstone-UCSF Institute of Genomic Immunology.
University of California, Los AngelesUnited States
Dr. Aria Fallah, MD, is an Assistant Professor in Neurosurgery at the University of California, Los Angeles (UCLA), with secondary appointments in Health Policy and Management. His research focuses on Evidence-Based Surgery , Clinical Trials , and Meta-Analyses for pediatric epilepsy surgery outcomes, including prognostic tools and comparative effectiveness studies . He actively participates in international collaborations like the CTSI and has published extensively in journals such as Epilepsia , Neurology , and Clinical Neurophysiology . University: University of California, Los Angeles Department: Neurosurgery Email: afallah@mednet.ucla.edu Dr. Fallah’s research integrates machine learning and deep learning to analyze high-frequency oscillations in epilepsy, aiming to refine diagnostic and therapeutic strategies. His recent work includes developing tools like PyHFO for oscillation detection and HOPS calculator for predicting seizure freedom after hemispherectomy. His publications highlight collaborations across institutions in pediatric epilepsy surgery , hemimegalencephaly , and thalamic neuromodulation . While no explicit awards or student advisement are listed, his contributions span clinical trials , neuroimmunology , and global neurosurgery initiatives , including work in Haiti.
Noah J. Cowan is a Professor of Mechanical Engineering at Johns Hopkins University's Whiting School of Engineering, with secondary appointments in Computer Science, Electrical & Computer Engineering, and Neuroscience. He is the founder and director of the Locomotion in Mechanical and Biological Systems (LIMBS) Laboratory, part of the Laboratory for Computational Sensing and Robotics. His research focuses on neuromechanics, robotics, and control theory, bridging neuroscience, biomechanics, and engineering. Cowan's work investigates how organisms achieve precise locomotion and applies these insights to advance robotics, neuroprosthetics, and rehabilitation technologies. Education: B.S. Electrical Engineering (Ohio State, 1995), M.S. and Ph.D. Electrical Engineering & Computer Science (University of Michigan, 1997/2001). Postdoctoral fellowship at UC Berkeley (2001–2003) before joining Johns Hopkins. Research Interests: Neuromechanics of motion, bio-inspired robotics, multisensory integration in animals (e.g., electric fish, Drosophila), and sensorimotor control in clinical contexts like cerebellar ataxia. His lab studies how neural circuits interact with biomechanics to produce movement, with applications to robotic design and neurological disorder treatments. Awards & Recognition: Presidential Early Career Award for Scientists and Engineers (2010), IEEE Fellow, NSF CAREER Award (2009), and multiple teaching and research excellence awards at Johns Hopkins. His work has been published in top journals like Nature , Proceedings of the National Academy of Sciences , and IEEE Transactions on Robotics . Outreach & Mentorship: Longtime mentor for high school and undergraduate students in STEM, leading programs like the Baltimore Ingenuity Project and WISE. Served as team leader for the STEM Achievement in Baltimore Elementary Schools (SABES) initiative. Key Projects: Development of the LIMBS Lab’s VR systems for animal studies, bioelectric navigation technologies for medical devices, and collaborations with clinicians on upper limb movement disorders. His team’s research on electric fish and fruit flies has revealed principles of adaptive control applicable to robotics and AI.
Massachusetts Institute of TechnologyUnited States
Dr. Canan Dagdeviren is an Associate Professor and LG Career Development Professor of Media Arts and Sciences at the Massachusetts Institute of Technology, where she directs the Conformable Decoders research group at the MIT Media Lab. She joined the MIT faculty in January 2017 and has established herself as a leading innovator in conformable biomedical devices. Education: Ph.D. in Materials Science and Engineering, University of Illinois at Urbana-Champaign M.Sc. in Materials Science and Engineering, Sabanci University, Istanbul, Turkey B.Sc. in Physics Engineering, Hacettepe University, Ankara, Turkey Dr. Dagdeviren's research focuses on creating mechanically adaptive electromechanical systems that can intimately integrate with biological surfaces for sensing, actuation, and energy harvesting. She believes vital information from nature and the human body is 'coded' in various physical patterns, and her work develops 'conformable decoders' to translate these patterns into beneficial signals and energy. Her research spans wearable and implantable medical devices, with particular emphasis on piezoelectric systems that can be twisted, folded, stretched, wrapped, and implanted onto curvilinear surfaces of the human body without damage or significant alteration in performance. Analysis of her recent publications reveals a strong focus on medical applications of conformable electronics, particularly in ultrasound technology for breast cancer detection, deep brain stimulation, and bladder monitoring. Her work consistently bridges materials science, electrical engineering, and medical applications, with increasing emphasis on practical healthcare solutions that can be deployed outside clinical settings. Major Scientific Awards: NSF CAREER Award (2021) 3M Non-Tenured Faculty Award (2021) MIT Technology Review's Top 35 Innovators Under 35 (2015) Forbes' Top 30 Under 30 in Science (2015) National Academy of Engineering US Frontiers of Engineering Symposium participant (2019) Frank E. Perkins Award for Excellence in Graduate Advising Aziz Sancar Science Award Dr. Dagdeviren actively mentors graduate students and has received recognition for her advising excellence. Her research is supported by significant grants including the NSF CAREER award and has resulted in numerous patents and commercialization opportunities. She has developed innovative cleanroom-based courses at MIT that train students in microfabrication techniques for biomedical devices. The Conformable Decoders research group operates a specialized cleanroom facility at the MIT Media Lab, enabling the development and fabrication of novel conformable electronic systems. The group's work has attracted attention from major media outlets including BBC, CNN, and Nature, and has potential applications across multiple medical specialties including neurology, oncology, and urology.
Univ-Prof. Dr. med. Malek Bajbouj serves as Director of the Institute for Affective Neuroscience and Emotion Modulation at Charité – University Medicine Berlin's Campus Benjamin Franklin (CBF), operating within the Department of Neurology, Neurosurgery and Psychiatry (CC 15). His position integrates clinical leadership with translational neuroscience research focused on severe mental illnesses. Dr. Bajbouj's research program centers on affective neuroscience and emotion dysregulation mechanisms in psychiatric disorders, particularly schizophrenia spectrum conditions and depression. He pioneers multimodal intervention approaches combining neuromodulation (tDCS), oxytocin augmentation, mindfulness therapies, and digital health tools. His work emphasizes translational biomarker development using neuroimaging, machine learning, and physiological stress parameter analysis to personalize treatment for treatment-resistant populations. Analysis of his 2023-2025 publications reveals three dominant research trajectories: (1) novel treatment combinations for negative symptoms in schizophrenia (oxytocin + mindfulness, yoga therapy); (2) real-world implementation of neuromodulation (at-home tDCS protocols, technical efficacy monitoring); and (3) global mental health responses to crises (pandemic impacts on vulnerable groups, culturally adapted refugee interventions). His methodology consistently employs rigorous randomized controlled trials with embedded biomarker studies. As director of his eponymous institute, Dr. Bajbouj leads a multidisciplinary team conducting neuroimaging studies, clinical trials, and international collaborations focused on emotion modulation pathways. The institute coordinates research across CC 15's clinical infrastructure at CBF Building V, with particular emphasis on bridging laboratory neuroscience with clinical psychiatry through the DepressionDC and OXYMIND trial frameworks.
